Literature DB >> 12565889

Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta.

Akiko Eto1, Tatsushi Muta, Soh Yamazaki, Koichiro Takeshige.   

Abstract

I kappa B-zeta, a new negative-regulator of nuclear factor-kappa B (NF-kappa B), is strongly induced by lipopolysaccharide or interleukin-1 beta stimulation, but not by tumor necrosis factor-alpha. Here, we analyzed the mechanisms for transcriptional induction of I kappa B-zeta. I kappa B-zeta mRNA was induced by overexpression of MyD88 or TRAF6, but not TRAF2. Stimulation of macrophages with peptidoglycan or CpG DNA, which activated Toll-like receptor 2 or 9, respectively, also resulted in I kappa B-zeta induction. Thus, activation of the MyD88-dependent signaling pathway, commonly found downstream of different Toll/interleukin-1 receptor (TIR) domains, is sufficient for I kappa B-zeta induction. The induction was inhibited by treatment with various inhibitors of NF-kappa B activation or by overexpressing I kappa B-alpha or beta, indicating essential roles for NF-kappa B in I kappa B-zeta induction. However, overexpression of the NF-kappa B subunits induced I kappa B-alpha, but not I kappa B-zeta. These results indicate the existence of another signal essential for I kappa B-zeta induction, which is specifically mediated by the TIR domain-mediated signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565889     DOI: 10.1016/s0006-291x(02)03082-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 2.  A structural guide to proteins of the NF-kappaB signaling module.

Authors:  Tom Huxford; Gourisankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

3.  IκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells.

Authors:  Yashaswini Kannan; Jianhua Yu; Raquel M Raices; Sudarshan Seshadri; Min Wei; Michael A Caligiuri; Mark D Wewers
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

4.  Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering.

Authors:  Ashley A Amini; Lakshmi S Nair
Journal:  Tissue Eng Part A       Date:  2013-02-19       Impact factor: 3.845

5.  Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication.

Authors:  Nicholas H Bergman; Karla D Passalacqua; Renee Gaspard; Lynne M Shetron-Rama; John Quackenbush; Philip C Hanna
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation.

Authors:  Susumu Matsuo; Soh Yamazaki; Koichiro Takeshige; Tatsushi Muta
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

7.  Inhibitory feedback control of NF-κB signalling in health and disease.

Authors:  Jack A Prescott; Jennifer P Mitchell; Simon J Cook
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

8.  Atypical IκB proteins - nuclear modulators of NF-κB signaling.

Authors:  Marc Schuster; Michaela Annemann; Carlos Plaza-Sirvent; Ingo Schmitz
Journal:  Cell Commun Signal       Date:  2013-04-11       Impact factor: 5.712

9.  Host transcription factors in the immediate pro-inflammatory response to the parasitic mite Psoroptes ovis.

Authors:  Stewart T G Burgess; Tom N McNeilly; Craig A Watkins; Alasdair J Nisbet; John F Huntley
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

10.  Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start site.

Authors:  Yuval Tabach; Ran Brosh; Yossi Buganim; Anat Reiner; Or Zuk; Assif Yitzhaky; Mark Koudritsky; Varda Rotter; Eytan Domany
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.